Caisse de Depot et Placement du Quebec (CDPQ)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1M Buy
+585,509
New +$25.2M 0.04% 357
2019
Q3
– Sell
-226,800
Closed -$5.79M – 843
2019
Q2
$5.79M Buy
+226,800
New +$5.61M 0.01% 289
2018
Q3
– Sell
-456,000
Closed -$10.5M – 784
2018
Q2
$10.5M Buy
+456,000
New +$10.8M 0.02% 251

Other funds holding NVO

Caisse de Depot et Placement du Quebec (CDPQ)'s NVO Position: Q2 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) opened a new position in Novo Nordisk (NVO) in Q2 2026: 585,509 shares worth $28.1M. The stake represents 0.04% of the portfolio and ranks #357 among its holdings. This is a return to the name: Caisse de Depot et Placement du Quebec (CDPQ) previously reported a position in NVO as recently as Q2 2019.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in NVO in Q2 2018 and has held it in 3 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Caisse de Depot et Placement du Quebec (CDPQ) held 585,509 shares of Novo Nordisk worth $28.1M as of Q2 2026.
  • Novo Nordisk was a new Caisse de Depot et Placement du Quebec (CDPQ) position in Q2 2026.
  • Novo Nordisk made up 0.04% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q2 2026, its #357 holding.
  • Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Novo Nordisk in Q2 2018 and has held it in 3 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q2 2026, filed 14 Aug 2026.